A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 3	2023-05-09		NCT05851014

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Genor Biopharma Co., Ltd.	2

52 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Jining Medical University	Jining	China	1
Anhui Cancer Hospital	Hefei	China	8
Betjing Tiantan Hosptial，Capital Medical University	Beijing	China	1
Chinese PLA General Hospial	Beijing	China	1
Chongqing University Cancer Hospital	Chongqing	China	54
First Affiliated Hospital of Gannan Medical University	Ganzhou	China	8
First Hosptial of Shanxi Medical University	Taiyuan	China	1
Fudan University Shanghai Cancer Center	Shanghai	China	257
Fujian Medical University Union Hospital	Fuzhou	China	107
General Hospital of Ningxia Medical University	Yingchuan	China	1
Guangxi Medical University Cancer Hospital	Nanning	China	4
Hangzhou Cancer Hospital	Hangzhou	China	2
Hubei Cancer Hospital	Wuhan	China	95
Hunan Cancer Hospital	Changsha	China	123
Jiangsu Province Hospital	Nanjing	China	89
Jiangxi Cancer Hospital	Nanchang	China	48
Jilin Cancer Hospital	Changchun	China	9
Jinan Central Hospital	Jinan	China	37
Liaocheng People's Hospital	Liaocheng	China	20
Liaoning Cancer Hospital & Institute	Shenyang	China	16
LinYi Cancer Hospital	Linyi	China	11
Maternal and Child Healh Hosptal of Guangdong Provrce	Guangzhou	China	1
Meizhou People's Hosptial	Meizhou	China	1
NingBo Medical Center LiHuiLi Hospital	Ningbo	China	3
Renmin Hospital of Wuhan University	Wuhan	China	42

Clinical trials